Table 4.

Association of baseline characteristics (major ECG abnormalities, demographics, and clinical characteristics) with incident cardiovascular events

	Hazard ratio (95% Confidence Interval)	P
Major ECG abnormality
Abnormality present	1.83 (1.12, 2.97)	0.015
Abnormality absent, other abnormality present	1.13 (0.78, 1.62)	0.51
No abnormalities	Ref.	-
Treatment Group (drug conservative vs. viral suppression)	1.43 (1.03, 1.99)	0.032
Age (year)	1.05 (1.03, 1.07)	<0.001
Gender (female vs. male)	0.60 (0.38, 0.96)	0.032
Race
Black	1.03 (0.70, 1.50)	0.90
Asian	0.45 (0.06, 3.29)	0.43
Other	0.79 (0.43, 1.45)	0.45
White	Ref	-
Smoking Status
Current	1.82 (1.19, 2.77)	0.006
Past	1.17 (0.73, 1.87)	0.51
Never	Ref	-
Total/HDL Cholesterol Ratio	1.04 (1.00, 1.09)	0.034
Baseline body mass index	1.00 (0.97, 1.04)	0.84
Diabetes (yes vs. no)	1.83 (1.16, 2.89)	0.010
Use of blood pressure-lowering drugs	2.00 (1.39, 2.88)	<0.001
Use of lipid lowering drugs	1.04 (0.69, 1.58)	0.84
Years since HIV diagnosis	1.00 (0.97, 1.04)	0.91
Baseline CD4 (per 100)	1.03 (0.97, 1.10)	0.35
Baseline HIV-RNA and antiretroviral status
Off Antiretroviral therapy	1.29 (0.76, 2.21)	0.35
On Antiretroviral therapy, HIV-RNA ≤ 400	0.99 (0.64, 1.53)	0.95
On Antiretroviral therapy, HIV-RNA > 400	Ref.	-